Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database

Pediatric Blood and Cancer

Volumn 57, Issue 6, 2011, Pages 943-949

  Ferrari, Andrea ^a   Sultan, Iyad ^b   Huang, Tseng Tien ^c   Rodriguez Galindo, Carlos ^d   Shehadeh, Ahmad ^b   Meazza, Cristina ^a   Ness, Kirsten K ^c   Casanova, Michela ^a   Spunt, Sheri L ^c,e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b KING HUSSEIN CANCER CENTER   (Jordan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Age; Epidemiology; Prognosis; SEER; Soft tissue sarcoma

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ALVEOLAR SOFT PART SARCOMA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHONDROMA; DISEASE ASSOCIATION; DISTANT METASTASIS; EWING SARCOMA; FEMALE; FIBROHISTIOCYTOMA; HEAD AND NECK CANCER; HUMAN; INFANT; KAPOSI SARCOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NERVE SHEATH TUMOR; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOID TUMOR; RHABDOMYOSARCOMA; SCHOOL CHILD; SEX DIFFERENCE; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; THORAX CANCER; TRUNK;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RHABDOMYOSARCOMA; SARCOMA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80052664254     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23252     Document Type: Article

References (29)

1. Weiss S, Goldblum J, editors. General considerations. In: Enzinger and weiss's soft tissue tumors. St. Louis, MO: CV Mosby; 2001. pp 1-19.
2. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2006). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
3. Surveillance, Epidemiology, and End Results (SEER) Program () SEER Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2008 Sub (1973-2006) -Linked To County Attributes-Total U.S. 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
4. Levi F, Randimbison L, Te VC, et al. Kaposi's sarcoma in Vaud and Neuchatel, Switzerland, 1978-2002. Eur J Cancer 2004; 40: 1630-1633.
5. Rouhani P, Fletcher CD, Devesa SS, et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12, 114 cases. Cancer 2008; 113: 616-627.
6. Toro JR, Travis LB, Wu HJ, et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26, 758 cases. Int J Cancer 2006; 119: 2922-2930.
7. Sultan I, Qaddoumi I, Yaser S, et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973-2005: An analysis of 2, 600 patients. J Clin Oncol 2009; 27: 3391-3397.
8. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999; 59: 74-79.
9. Ferrari A, Casanova M. Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 2005; 5: 283-294.
10. Joshi D, Anderson JR, Paidas C, et al. Age is an independent prognostic factor in rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 2004; 42: 64-73.
11. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 2003; 98: 571-580.
12. Hayes-Jordan AA, Spunt SL, Poquette CA, et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: Is age at diagnosis an important variable? J Pediatr Surg 2000; 35: 948-953; discussion 953-944.
13. Ferrari A, Casanova M, Collini P, et al. Adult-type soft tissue sarcomas in pediatric-age patients: Experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005; 23: 4021-4030.
14. Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1, 041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689.
15. Koea JB, Leung D, Lewis JJ, et al. Histopathologic type: An independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol 2003; 10: 432-440.
16. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2, 185 patients treated with anthracycline-containing first-line regimens-A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150-157.
17. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20: 791-796.
18. Eilber FC, Brennan MF, Eilber FR, et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 2004; 101: 2270-2275.
19. Ferrari A, Miceli R, Casanova M, et al. Adult-type soft tissue sarcomas in paediatric age: A nomogram-based prognostic comparison with adult sarcoma. Eur J Cancer 2007; 43: 2691-2697.
20. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 2005; 103: 402-408.
21. Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group. J Clin Oncol 2005; 23: 8422-8430.
22. Slater O, Shipley J. Clinical relevance of molecular genetics to paediatric sarcomas. J Clin Pathol 2007; 60: 1187-1194.
23. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004; 101: 627-634.
24. Hawkins WG, Hoos A, Antonescu CR, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 2001; 91: 794-803.
25. Little DJ, Ballo MT, Zagars GK, et al. Adult rhabdomyosarcoma: Outcome following multimodality treatment. Cancer 2002; 95: 377-388.
26. Fletcher CD. The evolving classification of soft tissue tumours: An update based on the new WHO classification. Histopathology 2006; 48: 3-12.
27. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996; 78: 656-663.
28. Lehnhardt M, Daigeler A, Hauser J, et al. The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol 2008; 97: 40-43.
29. Presant CA, Russell WO, Alexander RW, et al. Soft-tissue and bone sarcoma histopathology peer review: The frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 1986; 4: 1658-1661.